NSE · MANGALAM
Mangalam Drugs And Organics Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,445
of 5,072 stocks
▼ 581W
Peak #3,387 · 21 Sep 2026
Mangalam Drugs And Organics Limited is a microcap company in the Healthcare space and is seeing revenue contract sharply, has a subdued return on equity, and has promoters holding 36%.
Market Cap
50.38 Cr
P/E Ratio
—
P/B Ratio
0.49
ROE
-43.08%
ROCE
-27.34%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 57.12 Cr | 67.29 Cr | 58.49 Cr | 49.54 Cr |
| Net Profit | -7.64 Cr | -13.42 Cr | -9.84 Cr | -7.35 Cr |
| EPS | -4.83 | -8.48 | -6.21 | -4.64 |
| Operating Profit | -3.07 Cr | -10.19 Cr | -5.78 Cr | -7.44 Cr |
Shareholding pattern
Promoter
35.65%
Public
64.35%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 17 Sep 2018 | Other | Annual General Meeting |
| 21 Dec 2017 | Dividend | Interim Dividend Re 0.50 Per Share |
| 18 Sep 2017 | Other | Annual General Meeting |
| 22 Sep 2016 | Other | Annual General Meeting (Book Closure Dates Revised) |
| 26 Aug 2015 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.